Mapped the human genome and develop new drugs based on their research. Features a range of corporate data, investor information, news, and career opportunities.

Participates in therapeutics, blood testing and vaccines. Conducts research and development in the fields of recombinant technology, gene therapy, vaccines, small molecule discovery, and genomics.

Identifies sentinel nucleic acid expression profiles for use in developing assays associated with the prevention, diagnosis, and treatment of a variety of chronic diseases and catastrophic illnesses. Includes company history, staff and a list of current research projects.

Commercializes life science and chemical research conducted at The University of Surrey. Site includes details of products and current research.

Held in Milan, Italy, on 28-29 September 2005. Covers research, development, production, promotion and marketing, with details of participants and associated exhibition. [English and Italian]

Simplifying in order to accelerate genomics based product discovery and development. Has created technologies to better understand the role of genes in improving human health, animal health and agricultural vitality.

Creates new technologies and products for broad markets by innovations in the biomedical sciences.

Supplies Recombumin (Recombinant Human Albumin), albumin fusion proteins, high-yield yeast expression systems and protein purification.

Develops biological products such as proteins, enzymes, polypeptides and small molecules for applications in large segments of the agricultural, industrial, chemical and biopharmaceutical industries.

Focused on commercializing enzyme-based and other new technologies for the pulp and paper industry.

AMIET technological platform offers an alternative to more costly and environmentally unfriendly chemical and organic synthesis. Also, enables the use of enzymes in hydrophobic environments and protects the enzymes so as to maintain their innate 3-D structure.

Offers products for the health care, agriculture and industrial chemicals markets. Includes outline of expertise, and facilities for production, administration, research and development in four continents.

Apply the science of human genetics to drug and diagnostic discovery decisions. Maintains a database of DNA, sera, and tissue samples, linked to clinical information from patients worldwide.

Focuses on the development of technology platforms for genomic manipulations and gene discovery. Based in Canada.

Produces recombinant proteins and monoclonal antibodies for pharmaceutical use in the milk of transgenic animals.